Teysuno(TM) (S-1) Receives CHMP Positive Opinion For Approval As First-Line Therapy For Advanced Gastric Cancer
TOKYO, December 17, 2010 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (…